Recenti acquisizioni sul ruolo delle chemochine e dei recettori delle chemochine nella patogenesi della fibrosi polmonare idiopatica

Translated title of the contribution: Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis

Giuseppe Brunetti, Patrizia Pignatti

Research output: Contribution to journalArticle

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease characterized by fibrosis in the lung parenchyma and collagen deposition leading to respiratory failure. Different etiopathogenetic hypothesis have been formulated during the last years and many studies recently published demonstrated that in most of processes suggested for the onset and the development of IPF, chemokines and chemokine receptors are involved. Dysregulated expression of chemokines and their receptors during inflammatory processes might also alter the equilibrium between angiostatic and angiogenic processes leading to neovascularization in the lung tissue. Studies on chemokines/chemokine receptors could shed light on the mechanisms involved in IPF and draw new therapeutic strategies to block the progression of the disease.

Original languageItalian
Pages (from-to)90-96
Number of pages7
JournalRecenti Progressi in Medicina
Volume98
Issue number2
Publication statusPublished - Feb 2007

Fingerprint

Idiopathic Pulmonary Fibrosis
Chemokine Receptors
Chemokines
Lung
Respiratory Insufficiency
Lung Diseases
Disease Progression
Fibrosis
Collagen
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{abb2f07e93d34680bc1c1567b2091f67,
title = "Recenti acquisizioni sul ruolo delle chemochine e dei recettori delle chemochine nella patogenesi della fibrosi polmonare idiopatica",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease characterized by fibrosis in the lung parenchyma and collagen deposition leading to respiratory failure. Different etiopathogenetic hypothesis have been formulated during the last years and many studies recently published demonstrated that in most of processes suggested for the onset and the development of IPF, chemokines and chemokine receptors are involved. Dysregulated expression of chemokines and their receptors during inflammatory processes might also alter the equilibrium between angiostatic and angiogenic processes leading to neovascularization in the lung tissue. Studies on chemokines/chemokine receptors could shed light on the mechanisms involved in IPF and draw new therapeutic strategies to block the progression of the disease.",
keywords = "Chemokine receptors, Chemokines, Idiopathic pulmonary fibrosis",
author = "Giuseppe Brunetti and Patrizia Pignatti",
year = "2007",
month = "2",
language = "Italian",
volume = "98",
pages = "90--96",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "2",

}

TY - JOUR

T1 - Recenti acquisizioni sul ruolo delle chemochine e dei recettori delle chemochine nella patogenesi della fibrosi polmonare idiopatica

AU - Brunetti, Giuseppe

AU - Pignatti, Patrizia

PY - 2007/2

Y1 - 2007/2

N2 - Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease characterized by fibrosis in the lung parenchyma and collagen deposition leading to respiratory failure. Different etiopathogenetic hypothesis have been formulated during the last years and many studies recently published demonstrated that in most of processes suggested for the onset and the development of IPF, chemokines and chemokine receptors are involved. Dysregulated expression of chemokines and their receptors during inflammatory processes might also alter the equilibrium between angiostatic and angiogenic processes leading to neovascularization in the lung tissue. Studies on chemokines/chemokine receptors could shed light on the mechanisms involved in IPF and draw new therapeutic strategies to block the progression of the disease.

AB - Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible lung disease characterized by fibrosis in the lung parenchyma and collagen deposition leading to respiratory failure. Different etiopathogenetic hypothesis have been formulated during the last years and many studies recently published demonstrated that in most of processes suggested for the onset and the development of IPF, chemokines and chemokine receptors are involved. Dysregulated expression of chemokines and their receptors during inflammatory processes might also alter the equilibrium between angiostatic and angiogenic processes leading to neovascularization in the lung tissue. Studies on chemokines/chemokine receptors could shed light on the mechanisms involved in IPF and draw new therapeutic strategies to block the progression of the disease.

KW - Chemokine receptors

KW - Chemokines

KW - Idiopathic pulmonary fibrosis

UR - http://www.scopus.com/inward/record.url?scp=33947233191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947233191&partnerID=8YFLogxK

M3 - Articolo

C2 - 17439069

AN - SCOPUS:33947233191

VL - 98

SP - 90

EP - 96

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 2

ER -